Amyloid Center of Excellence Selected for AHA ATTR-CM Discovery Initiative

The WashU Medicine Amyloid Center of Excellence has been selected as one of just 10 centers nationwide to participate in the American Heart Association’s ATTR-CM Discovery Initiative, a three-year program aimed at transforming care for patients with transthyretin amyloid cardiomyopathy (ATTR-CM).

The initiative brings together a select group of leading medical centers with the shared goal of understanding and improving the ATTR system of care, optimizing the patient pathway from initial identification through ongoing disease management.